Literature DB >> 24042480

Neuro-oncology: Glioblastoma prognosis linked to neuronal PD-L1 expression in tumour-adjacent tissue.

Katie Kingwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24042480     DOI： 10.1038/nrneurol.2013.197

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients.

Authors:  Yawei Liu; Robert Carlsson; Malene Ambjørn; Maruf Hasan; Wiaam Badn; Anna Darabi; Peter Siesjö; Shohreh Issazadeh-Navikas
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167
  1 in total
  9 in total

1.  FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Authors:  Jun Yan; Ling-Yuan Kong; Jiemiao Hu; Konrad Gabrusiewicz; Denada Dibra; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  J Natl Cancer Inst       Date:  2015-05-13       Impact factor: 13.506

2.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis.

Authors:  Ramy R Saleh; Jordan L Scott; Nicholas Meti; Danielle Perlon; Rouhi Fazelzad; Alberto Ocana; Eitan Amir
Journal:  Mol Diagn Ther       Date:  2022-02-01       Impact factor: 4.074

4.  Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.

Authors:  Elias J Sayour; Luis Sanchez-Perez; Catherine Flores; Duane A Mitchell
Journal:  J Immunother Cancer       Date:  2015-04-21       Impact factor: 13.751

5.  Hyperbaric oxygen inhibits production of CD3+ T cells in the thymus and facilitates malignant glioma cell growth.

Authors:  Yong-Gang Wang; Jiang Long; Dong-Chuan Shao; Hai Song
Journal:  J Int Med Res       Date:  2018-05-22       Impact factor: 1.671

6.  Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.

Authors:  Christophe Glorieux; Xiaojun Xia; Xin You; Zining Wang; Yi Han; Jing Yang; Gauthier Noppe; Christophe de Meester; Jianhua Ling; Annie Robert; Hui Zhang; Sheng-Ping Li; Huamin Wang; Paul J Chiao; Li Zhang; Xiaobing Li; Peng Huang
Journal:  J Adv Res       Date:  2021-12-21       Impact factor: 12.822

7.  Clinical significance for diagnosis and prognosis of POP1 and its potential role in breast cancer: a comprehensive analysis based on multiple databases.

Authors:  Xiao He; Ji Wang; Honghao Yu; Wenchang Lv; Yichen Wang; Qi Zhang; Zeming Liu; Yiping Wu
Journal:  Aging (Albany NY)       Date:  2022-09-09       Impact factor: 5.955

Review 8.  Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Authors:  Matthias Preusser; Anna S Berghoff; Wolfgang Wick; Michael Weller
Journal:  Clin Neuropathol       Date:  2015 Nov-Dec       Impact factor: 1.368

Review 9.  Targeting immune checkpoints in malignant glioma.

Authors:  Xuhao Zhang; Shan Zhu; Tete Li; Yong-Jun Liu; Wei Chen; Jingtao Chen
Journal:  Oncotarget       Date:  2017-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.